In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Edurant Drug Master File in Korea (Edurant KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Edurant. The MFDS reviews the Edurant KDMF as part of the drug registration process and uses the information provided in the Edurant KDMF to evaluate the safety and efficacy of the drug.
After submitting a Edurant KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Edurant API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Edurant suppliers with KDMF on PharmaCompass.